In vivo affinity maturation of the CD4 domains of an HIV-1-entry inhibitor

Andi Pan(Broad Institute), Wenhui He(Scripps Research Institute)

Nature Biomedical Engineering

December 5, 2024

10.1038/s41551-024-01289-1

Cited by 14

Related Papers

Heavy-chain CDR3-engineered B cells facilitate in vivo evaluation of HIV-1 vaccine candidates

|Immunity|2023|16

<i>In vivo</i> affinity maturation of the HIV-1 Env-binding domain of CD4

|bioRxiv (Cold Spring Harbor Laboratory)|2024|1

Heavy-chain CDR3-engineered B cells facilitate <i>in vivo</i> evaluation of HIV-1 vaccine candidates

|bioRxiv (Cold Spring Harbor Laboratory)|2022|0

In vivo affinity maturation of the HIV-1 Env-binding domain of CD4

|Research Square|2024|0